| mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.009 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
| mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.01 |
| mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.01 |
| mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.01 |
| mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.01 |
| mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.01 |
| mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.01 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |